1718102211788

FAQ's

Answer : The stem cells market was reached at USD 9.3 billion in 2020 and is anticipated to reach around USD 17.79 billion by 2027.

Answer : The global stem cells market is expected to exhibit a CAGR of 8.61% during the forecast period 2020-2027.

Answer : Since past few years, stem cells market is growing with the increasing investment in stem cell-based research by biopharmaceutical and pharmaceutical firm along with the success of regenerative medicines. Stem cells market is growth is backed by escalating number of clinical trials across the world. Some of the major factors driving the growth of the stem cells market include advancement in stem cell manufacturing technology as well as increasing harvest awareness regarding therapeutic potency. High occurrences of infections have steered the development of vaccines using various human diploid and non-tumorigenic cell lines.

Answer : The adult stem cells dominated the global market in 2019 and is expected to hold the dominance over the forecast period.

Answer : North America held the largest share in the market and is anticipated to continue its dominance over the forecast period due to existence of organized and developed healthcare systems which uplift research and development in the U.S. and Canada.

Answer : Asia Pacific is likely to grow with the highest Compound Annual Growth Rate (CAGR) owing to wide usage of stem cells in regenerative medicines particularly in the sector of dermatology.

Answer : Stem Cells market is highly competitive and includes several major players such as STEMCELL Technologies, Inc., Osiris therapeutics, Inc., Cynata Therapeutics, Human Longevity, Inc., Advanced Cell Technology, Inc., BIOTIME, Inc.Mesoblast Limited, Promethera Biosciences S.A. N.V., Merck Group, Takara Bio Group.

Answer : In terms of application segments the oncology segments exhibited the highest growth rate owing to the existence of various pipeline products for the treatment of cancer and tumors.